FDA Alerts

FDA Alerts
FDA Alerts
FDA Approves New Hepatitis C Treatment Option
07/26/2016
The FDA has approved a new treatment option for patients with genotype 1 chronic hepatitis C virus.
07/26/2016
roundup
eye
roundup
FDA Roundup: Generic Rosuvastatin, Psoriasis Recommendation, Dry Eye
07/21/2016
The FDA has approved generic forms of rosuvastatin and a new option for dry eye disease and has heard recommendations to approve a new psoriasis drug.
07/21/2016
FDA
FDA
FDA Approves Pediatric Treatment for Hereditary Angioedema
07/20/2016
The FDA has approved a treatment for hereditary angioedema attacks in pediatric patients.
07/20/2016
FDA Alerts
FDA Alerts
FDA Approves New Weight Loss Drug Formulation
07/19/2016
The FDA has approved a new formulation for lorcaserin HCI for the management of weight in adults.
07/19/2016
FDA Alerts
FDA Alerts
FDA Approves 2016-2017 Influenza Vaccine Formulation
07/13/2016
The FDA has approved the 2016-2017 formulation of Flublok—an egg-free, protein-based vaccine—for prevention of seasonal influenza.
07/13/2016
FDA Alerts
FDA Alerts
FDA seeks more data on over-the-counter hand sanitizers
06/29/2016
...
06/29/2016
FDA Alerts
FDA Alerts
FDA Approves New Hep C Treatment
06/28/2016
The FDA approved Epclusa (fixed-dose combination of sofosbuvir and velpatasvir) to treat adult patients with chronic hepatitis C virus with and without cirrhosis.
06/28/2016
Nephrology
Nephrology
FDA Raises Kidney Warning with SGLT2 Inhibitors
06/15/2016
The FDA strengthened its warning of kidney injury in patients with type 2 diabetes taking 2 SGLT2 inhibitors.
06/15/2016
FDA Alerts
FDA Alerts
FDA Warning Leads to Increased Hospitalization, Death
06/13/2016
A study examined the consequences of an FDA warning recommending against the prescription of the antidepressant citalopram at dosages higher than 40 mg/day.
06/13/2016
Gastroenterology
Gastroenterology
FDA: Potentially Fatal Cardiac Events Possible with High Doses of Loperamide
06/08/2016
The FDA has issued a warning of serious and potentially fatal cardiac problems associated with the higher-than-recommended use of the antidiarrheal drug loperamide (Imodium).
06/08/2016